Mankind Pharma’s Q3 FY25 net profit declined 16% YoY to ₹385 crore despite a 24% revenue increase to ₹3,230 crore. Domestic revenues rose 17%, exports more than doubled, and consumer health grew 30%.
Vodafone Idea approves Rs 20,000 cr fundraise plans in a fight for survival
Vodafone Idea’s board has approved raising up to Rs 20,000 crore through equity and debt to strengthen its financial position. The capital infusion aims to